Satisfaction and Efficacy Outcomes When Switching from Injectable Disease-Modifying Therapies to Fingolimod in PREFERMS: Effect of Previous Treatment

被引：0
|
作者：
Hunter, Samuel F. [1 ]
Cree, Bruce A. C. [2 ]
Meng, Xiangyi [3 ]
Schofield, Lesley [3 ]
Kolodny, Scott [3 ]
Tenenbaum, Nadia [3 ]
Thomas, Florian P. P. [4 ]
机构：
[1] Adv Neurosci Inst, Franklin, TN USA
[2] UCSF Weill Inst Neurosci, San Francisco, CA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Hackensack Univ Med Ctr, Hackensack, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P019
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] The CLARITY study: efficacy outcomes among patients who received disease-modifying therapies prior to treatment with cladribine tablets
    Vermersch, P.
    Rammohan, K.
    Damian, D.
    Jack, D.
    Harty, G.
    Wong, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 301 - 302
  • [32] TREATMENT PATTERNS AND PERSISTENCE TO ORAL AND INJECTABLE MULTIPLE SCLEROSIS DISEASE-MODIFYING THERAPIES BETWEEN THE UNITED STATES AND EUROPE
    Galaznik, A.
    Ransom, J.
    Shilnikova, A.
    Rusli, E.
    Lempernesse, B.
    Berger, M.
    VALUE IN HEALTH, 2020, 23 : S277 - S277
  • [33] Effect of oral versus injectable disease-modifying therapies on the immunological profiles and gut microbiota in Multiple Sclerosis patients
    Zhu, Yunjiao
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 69 - 69
  • [34] Injectable versus oral first-line disease-modifying therapies: results from italian ms register
    D'Amico, E.
    Zanghi, A.
    Romeo, M.
    Cocco, E.
    Maniscalco, G. T.
    Bresciamorra, V.
    Paolicelli, D.
    De Luca, G.
    Galgani, S.
    Amato, M. P.
    Salemi, G.
    Inglese, M.
    Confalonieri, P. A.
    Lus, G.
    Gallo, A.
    Vianello, M.
    Onofrj, M.
    Pozzilli, C.
    Filippi, M.
    Trojano, M.
    Patti, F.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 285 - 286
  • [35] Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
    Emanuele D’Amico
    Aurora Zanghì
    Marzia Romeo
    Eleonora Cocco
    Giorgia Teresa Maniscalco
    Vincenzo Brescia Morra
    Damiano Paolicelli
    Giovanna De Luca
    Simonetta Galgani
    Maria Pia Amato
    Giuseppe Salemi
    Matilde Inglese
    Paolo Agostino Confalonieri
    Giacomo Lus
    Carlo Avolio
    Antonio Gallo
    Marika Vianello
    Marco Onofrj
    Massimo Filippi
    Maria Trojano
    Francesco Patti
    Neurotherapeutics, 2021, 18 : 905 - 919
  • [36] Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
    D'Amico, Emanuele
    Zanghi, Aurora
    Romeo, Marzia
    Cocco, Eleonora
    Maniscalco, Giorgia Teresa
    Brescia Morra, Vincenzo
    Paolicelli, Damiano
    De Luca, Giovanna
    Galgani, Simonetta
    Amato, Maria Pia
    Salemi, Giuseppe
    Inglese, Matilde
    Confalonieri, Paolo Agostino
    Lus, Giacomo
    Avolio, Carlo
    Gallo, Antonio
    Vianello, Marika
    Onofrj, Marco
    Filippi, Massimo
    Trojano, Maria
    Patti, Francesco
    NEUROTHERAPEUTICS, 2021, 18 (02) : 905 - 919
  • [37] Real-world Effectiveness Of Initial Treatment With Newer Versus Injectable Disease-modifying Therapies In Pediatric Multiple Sclerosis
    Krysko, K. M.
    Graves, J. S.
    Rensel, M.
    Weinstock-Guttman, B.
    Rutatangwa, A.
    Aaen, G.
    Anita, B.
    Benson, L.
    Chitnis, T.
    Gorman, M.
    Goyal, M. S.
    Harris, Y.
    Krupp, L.
    Lotze, T.
    Mar, S.
    Moodley, M.
    Ness, J.
    Rodriguez, M.
    Rose, J.
    Schreiner, T.
    Tillema, J.
    Waltz, M.
    Casper, T.
    Waubant, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 46 - 47
  • [38] Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis
    Krysko, Kristen
    Graves, Jennifer
    Rensel, Mary
    Weinstock-Guttman, Bianca
    Rutatangwa, Alice
    Aaen, Gregory
    Belman, Anita
    Benson, Leslie
    Chitnis, Tanuja
    Gorman, Mark
    Goyal, Manu
    Harris, Yolanda
    Krupp, Lauren
    Lotze, Timothy
    Mar, Soe
    Moodley, Manikum
    Ness, Jayne
    Rodriguez, Moses
    Rose, John
    Schreiner, Teri
    Tillema, Jan-Mendelt
    Waltz, Michael
    Casper, T. Charles
    Waubant, Emmanuelle
    NEUROLOGY, 2020, 94 (15)
  • [39] Effects of the Treatment Burden Associated with Injectable Disease-Modifying Therapies on Self-Reported Health Utilities in Multiple Sclerosis
    Smith, Kevin
    Trisolini, Michael
    Eckert, Benjamin
    Vollmer, Timothy
    NEUROLOGY, 2009, 72 (11) : A79 - A79
  • [40] Treatment satisfaction with injectable disease-modifying therapy in patients with isolated demyelinating syndrome or relapsing-remitting multiple sclerosis
    Fernandez, O.
    Forner, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 282 - 282
12345